A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/715 (2006.01) A61K 31/734 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2410013
Certain alginates exhibit a superior ability to inhibit the proteolytic activity of pepsin and/or gastric juice. In particular, alginates having a molecular weight between 40,000 and 350,000 exhibit a superior inhibition of the proteolytic activity of pepsin and gastric juice by over 50 % when measured using an N-terminal assay.
Certains alginates possèdent une capacité supérieure d'inhibition de l'activité protéolytique de la pepsine et/ou du suc gastrique. En particulier, les alginates présentant un poids moléculaire compris entre 40000 et 35000 possèdent une capacité supérieure d'inhibition de l'activité protéolytique de la pepsine et du suc gastrique, de plus de 50 %, mesurée à l'aide d'un dosage de groupes N terminaux.
Dettmar Peter William
Hampson Frank Chadwick
Pearson Jeffrey Peter
Sunderland Andrew Michael
Fetherstonhaugh & Co.
Reckitt Benckiser Healthcare (uk) Limited
LandOfFree
Pepsin inhibition by alginates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pepsin inhibition by alginates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pepsin inhibition by alginates will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799519